In this supplement to Internal Medicine News , Christine Frissora, MD provides an overview of the burdens that patients with IBS-D experience. Three clinical efficacy and safety studies surrounding an FDA-approved treatment are also examined.
IBS-D diagnosis and treatment challenges
The role of microbial imbalance and altered gut microbiota
A treatment option for relief of IBS-D symptoms